CVS Health (NYSE:CVS) Shares Down 0.2% – Time to Sell?

CVS Health Co. (NYSE:CVS) dropped 0.2% during trading on Monday . The company traded as low as $55.25 and last traded at $56.35. Approximately 3,421,627 shares traded hands during trading, a decline of 73% from the average daily volume of 12,896,416 shares. The stock had previously closed at $56.48.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research reports. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Mizuho reduced their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target on the stock in a research note on Tuesday, December 3rd. Finally, Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a report on Friday, November 15th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Stock Down 1.3 %

The stock has a market capitalization of $69.99 billion, a PE ratio of 14.12, a PEG ratio of 0.62 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The business has a 50 day moving average of $51.11 and a two-hundred day moving average of $56.06.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the prior year, the company posted $2.21 earnings per share. CVS Health’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts predict that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.78%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Hedge Funds Weigh In On CVS Health

Several hedge funds have recently made changes to their positions in the company. SRS Capital Advisors Inc. grew its position in CVS Health by 28.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 2,552 shares of the pharmacy operator’s stock worth $115,000 after purchasing an additional 569 shares during the period. Smartleaf Asset Management LLC lifted its holdings in CVS Health by 7.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 10,725 shares of the pharmacy operator’s stock valued at $471,000 after acquiring an additional 760 shares during the period. Cape Investment Advisory Inc. grew its stake in shares of CVS Health by 54.9% during the 4th quarter. Cape Investment Advisory Inc. now owns 1,275 shares of the pharmacy operator’s stock worth $57,000 after purchasing an additional 452 shares during the period. Keynote Financial Services LLC boosted its holdings in CVS Health by 14.2% during the fourth quarter. Keynote Financial Services LLC now owns 32,385 shares of the pharmacy operator’s stock worth $1,454,000 after buying an additional 4,034 shares in the last quarter. Finally, Proffitt & Goodson Inc. increased its holdings in CVS Health by 10.6% in the fourth quarter. Proffitt & Goodson Inc. now owns 11,321 shares of the pharmacy operator’s stock valued at $508,000 after buying an additional 1,084 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.